IVI Fosters a Middle Ground for Value Assessment Discussions
In an article published on AJMC.com, IVI'sJennifer Bright and Mark Linthicum argue value assessment stakeholders need to have transparent discussions about value assessment and understand what value means from other points of view. Read the [...]
Bright at Xtelligent Media Panel: Value Assessment Platform Must Go Beyond Population Averages
IVI's Jennifer Bright participated in a panel of discussion at the recent Value-Based Summit, organized by Xtelligent media. Bright's panel, "Healthcare Quality Measurement," examined how healthcare stakeholders are looking at insights derived from measurement initiatives [...]
PRESS RELEASE: IVI Discusses the Open-Source Value Project and Its Relevance in Modernizing Cost-Effectiveness Analysis
ISPOR Conference Examines How New Approaches to Value Assessment May Help Move Toward More Informed Pricing Washington, D.C. –- October 19, 2018 -- At the ISPOR Summit 2018, the lead scientific advisor for the Innovation [...]
PRESS RELEASE: IVI’s Executive Director Discusses Moving Beyond the Average in Value Assessment
IVI’s Executive Director Discusses Moving Beyond the Average in Value Assessment at Xtelligent Media’s Value Based Summit 2018 Boston, MA –- October 18, 2018 -- Value Assessment 2.0 requires building assessment models that account for [...]
-
PRESS RELEASE: IVI Releases Public Feedback and Technical Expert Panel Recommendations for Open-Source Platform Model to Assess Outcomes and Value of Rheumatoid Arthritis TherapiesPRESS RELEASE: IVI Releases Public Feedback and Technical Expert Panel Recommendations for Open-Source Platform Model to Assess Outcomes and Value of Rheumatoid Arthritis Therapies
PRESS RELEASE: IVI Releases Public Feedback and Technical Expert Panel Recommendations for Open-Source Platform Model to Assess Outcomes and Value of Rheumatoid Arthritis Therapies
Priorities Emerged Which Will Shape Version 2.0 of IVI’s RA Model Los Angeles, CA – September 20, 2018 -- The Innovation and Value Initiative (IVI) today released public feedback and recommendations from its Technical Expert [...]
Precision Benefit Design: How should the arrival of precision medicine affect health plan benefit design?
Advances in precision medicine offer the promise of tremendous gains in patient health over the coming decades. Headlines in the popular press as well as discussions at academic conferences tout the potential benefits of precision [...]
Is One Answer Good Enough for All? Defining Value in Healthcare
While it makes sense for value assessment to be woven into healthcare decision making, relying on a single method to measure value and using this metric to restrict treatment access is shortsighted. IVI's Jennifer Bright [...]
Why Quality Measures Must Reflect Patient Values, Care Experience
There isn't an easy answer to assessing value in healthcare, but IVI is working to tackle the problems through considerable research and experimentation by developing an open-source value platform that considers no only clinical factors, [...]
Is Using Centralized Value Assessment to Make Centralized Pricing Decisions the Most Effective Path Forward?
The Pink Sheet article described comment letters to HHS’ drug pricing blueprint recommending that cost-effectiveness analyses by ICER could help promote value-based pricing in government-sponsored insurance. While IVI concurs value assessment is noble, worthwhile and [...]
IVI Provides Insight into CVS Health’s Decision to Include Cost-per-QALY Analyses from ICER into Formulary Decision-Making
CVS Health's pharmacy benefit management (PBM) division, CVS Caremark, recently announced their decision to rely exclusively on the analyses of the Institute for Clinical and Economic (ICER) in a new drug management program. IVI's Director [...]
How to Improve Value Assessment
In an op-ed published in Healthcare Business News, IVI's Executive Director, Jennifer Bright, describes four essential steps necessary to better measure value in healthcare: Better value measurement must incorporate the patient perspective into all assessment [...]
PRESS RELEASE: IVI Responds to HHS’ Blueprint Saying Lowering Healthcare Costs Requires Improving Value Assessment
IVI Says Moving Beyond Cost Effectiveness by Evaluating Treatments Based on Unique Patient Characteristics and Preferences is Imperative Los Angeles, CA – July 16, 2018 -- If we are going to truly harness data [...]